Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsGlenmark pharmaceuticals

    Glenmark Pharmaceuticals

    Jump to

    • Stocks to Watch Today: HCLTech, Akzo Nobel, Kaynes Tech, Ahluwalia Contracts, Saregama, NBCC, IOB, Ola Electric, Nephrocare, Park Hospitals in focus on 17 December

      Stocks to Watch, 17 December: Stocks like Akzo Nobel India, Kaynes Technology India, Ahluwalia Contracts, Saregama India, HCL Technologies, NBCC,Glenmark Pharma, Indian Overseas Bank, Sequent Scientific, Kajaria Ceramics, Ola Electric Mobility, Nephrocare Health Services, and Park Medi World will be in focus on December 17.

    • Buy Glenmark Pharmaceuticals; target of Rs 2300: Deven Choksey

      Deven Choksey is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 2300 in its research report dated November 18, 2025.

    • Stocks to Watch Today: Glenmark Pharma, Alkem Labs, Syrma SGS, Vikran Engineering, Ather Energy, Jindal Stainless, Vodafone, Baazar Style in focus on 11 November

      Stocks to Watch, 11 November: Stocks like Bajaj Finance, Vodafone Idea, Baazar Style Retail, Bajaj Consumer Care, Gujarat Gas, Triveni Turbine, Jindal Stainless, Power Mech Projects, Ather Energy, Vikran Engineering, Sula Vineyards, Syrma SGS Technology, Doms Industries, Alkem Laboratories, and Dr Reddy’s Laboratories will be in focus on November 11.

    • Buy Glenmark Pharmaceuticals; target of Rs 2300: Deven Choksey

      Deven Choksey is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 2300 in its research report dated September 02, 2025.

    • Sell Glenmark Pharmaceuticals; target of Rs 1570: ICICI Securities

      ICICI Securities is bearish on Glenmark Pharmaceuticals has recommended sell rating on the stock with a target price of Rs 1570 in its research report dated August 19, 2025.

    • Stocks to Watch Today: Glenmark, Inox Wind, Zaggle, Easy Trip, KEC International, EMS, Torrent Power, JK Cement, Globe Civil, Indian Bank in focus on 18 August

      Stocks to Watch, 18 August: Stocks like Glenmark Pharma, Inox Wind, Zaggle Prepaid Ocean Services, Easy Trip Planners, KEC International, EMS, Torrent Power, JK Cement, Globe Civil Projects, Indian Bank, ICICI Bank, ONGC, and Tata Power will be in focus on August 18.

    • Sell Glenmark Pharmaceuticals; target of Rs 1620: ICICI Securities

      ICICI Securities is bearish on Glenmark Pharmaceuticals has recommended sell rating on the stock with a target price of Rs 1620 in its research report dated July 18, 2025.

    • Stocks to Watch Today: TCS, Tata Elxsi, Anand Rathi, IREDA, Hindustan Unilever, Glenmark Pharma, Aegis Logistics, Meta Infotech in focus on 11 July

      Stocks to Watch, 11 July: Stocks like Tata Consultancy Services, Tata Elxsi, Anand Rathi Wealth, Indian Renewable Energy Development Agency IREDA, Hindustan Unilever, Glenmark Pharma, Aegis Logistics, and Meta Infotech will be in focus on July 11.

    • Stocks to Watch Today: Indian Hotels, CCL Products, DCM Shriram, Ather Energy, Senores Pharma, Paras Defence, Glenmark in focus on 6 May

      Stocks to Watch, 06 May: Stocks like Computer Age Management Services, Bombay Dyeing & Manufacturing Company, Zee Media Corporation, Jammu & Kashmir Bank, Prataap Snacks, Hind Rectifiers, Cigniti Technologies, Coforge, Indian Energy Exchange, Paras Defence and Space Technologies, and IRCON International will be in focus on May 6.

    • Stocks to Watch Today: Hero MotoCorp, Zydus Life, Lupin, Sonata Software, Dalmia Bharat, Paytm, Infosys, Angel One, Wipro in focus on 17 April

      Stocks to Watch, 17 Apr: Stocks like Waaree Renewable Technologies, GTPL Hathway, Prestige Estates Projects, UltraTech Cement, Bharat Heavy Electricals, Indian Railway Finance Corporation, SML Isuzu, Petronet LNG, SBI Cards and Payment Services, Glenmark Pharmaceuticals, Tata Steel, Ballarpur Industries, and Karnataka Bank will be in focus on April 17.

    • Glenmark shares crash 6% after USFDA order discloses 39 drugs recalled from US market

      The US FDA however noted that the recall was a voluntary one, issued by the firm itself on March 13 this year.

    • Stocks to Watch Today: Manappuram Finance, Hero MotoCorp, Hindalco, Glenmark, TCS, Lloyds Metals, CDSL, RailTel in focus on 21 March

      Stocks to Watch, Mar 21: Stocks like Lloyds Metals and Energy, Ashoka Buildcon, CG Power and Industrial Solutions, Unichem Laboratories, Happiest Minds Technologies, Piramal Pharma, Power Finance Corporation, Asian Paints, Container Corporation of India, Tamilnad Mercantile Bank, and Endurance Technologies will be in focus on March 21.

    • Buy Glenmark Pharmaceuticals; target of Rs 1768: KR Choksey

      KR Choksey is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1768 in its research report dated February 18, 2025.

    • Buy Glenmark Pharmaceuticals; target of Rs 1894: KR Choksey

      KR Choksey is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1894 in its research report dated November 18, 2024.

    • Stock Radar: Dr Reddys, Mankind, Adani Total Gas, Aarti Drugs, BHEL, HFCL, Vodafone in focus on Monday

      Dreamfolks Services, Sterling and Wilson Renewable Energy, Ugro Capital, Aster DM Healthcare, ONGC, Ramco Cements, Tata Steel, Avalon Technologies, and HDFC Bank will also be in focus on September 23.

    • Trade Spotlight: How should you trade UPL, Glenmark Pharma, GSPL, Radico Khaitan, RVNL, and others on Monday?

      The market may consolidate before showing further upward movement in the coming sessions. Below are some trading ideas for the near term.

    • Reduce Glenmark Pharmaceuticals: target of Rs 1345: ICICI Securities

      ICICI Securities recommended reduce rating on Glenmark Pharmaceuticals with a target price of Rs 1345 in its research report dated August 16, 2024.

    • Buy Glenmark Pharmaceuticals; target of Rs 1894: KR Choksey

      KR Choksey is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1894 in its research report dated August 20, 2024.

    • Stock Radar: Ola Electric, Hindustan Zinc, Power Mech Projects, KNR Constructions, Glenmark Pharma in focus on Friday

      Relicab Cable Manufacturing, Shanti Educational Initiatives, Kiri Industries, Tata Steel, Hinduja Global Solutions, and Polyplex Corporation will also be in focus on August 16.

    • Glenmark Pharma hits 52-week high on USFDA approval for Topiramate Capsules

      Glenmark Pharmaceuticals Share Price | Glenmark’s current portfolio consists of 198 products authorized for distribution in the US market place and 50 ANDA’s pending approval with the US FDA.

    • Stock Radar: Asian Paints, Aditya Birla Money, Just Dial, Airtel, Paytm in focus on Thursday

      L&T Finance, Network18 Media and Investments, TV18 Broadcast, Alok Industries, and KEC International will also be in focus on Thursday.

    • Glenmark Pharma gets USFDA nod for generic anti-inflammatory drug

      The company has received approval from the US Food and Drug Administration (USFDA) for Acetaminophen and Ibuprofen tablets (250 mg/125 mg), the Mumbai-based drug maker said in a statement.

    • Glenmark Pharma shares gain on US FDA nod for acetaminophen, ibuprofen tablets

      Glenmark Pharmaceuticals Share Price | The share touched a 52-week high of Rs 1,095.95 and a 52-week low of Rs 516.65 on 25 April, 2024 and 26 April, 2023, respectively.

    • Buy Glenmark Pharmaceuticals; target of Rs 1266: KR Choksey

      KR Choksey is bullish on Glenmark Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1266 in its research report dated April 05, 2024.

    • Accumulate Glenmark Pharmaceuticals; target of Rs 984: KR Choksey

      KR Choksey recommended Accumulate rating on Glenmark Pharmaceuticals with a target price of Rs 984 in its research report dated February 22, 2024.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347